NASDAQ:CTSO
$3.56
(
10.90%
)
Friday, 3rd Feb 2023
Cytosorbents Corporation Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.75 | $3.77 | Friday, 3rd Feb 2023 CTSO stock ended at $3.56. This is 10.9% more than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 17.77% from a day low at $3.20 to a day high of $3.77. |
| 90 days | $1.03 | $3.77 | |
| 52 weeks | $1.03 | $4.15 |
Historical Cytosorbents Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $3.22 | $3.77 | $3.20 | $3.56 | 305 145 |
| 2023-02-02 | $3.07 | $3.23 | $3.01 | $3.21 | 148 558 |
| 2023-02-01 | $2.82 | $3.10 | $2.76 | $3.03 | 198 004 |
| 2023-01-31 | $2.35 | $2.91 | $2.30 | $2.86 | 235 028 |
| 2023-01-30 | $2.37 | $2.39 | $2.28 | $2.28 | 30 765 |
| 2023-01-27 | $2.35 | $2.40 | $2.32 | $2.37 | 49 646 |
| 2023-01-26 | $2.53 | $2.56 | $2.21 | $2.33 | 89 005 |
| 2023-01-25 | $2.27 | $2.57 | $2.25 | $2.53 | 194 325 |
| 2023-01-24 | $2.14 | $2.45 | $2.14 | $2.33 | 149 132 |
| 2023-01-23 | $2.11 | $2.19 | $2.11 | $2.14 | 93 184 |
| 2023-01-20 | $2.15 | $2.21 | $2.09 | $2.10 | 27 110 |
| 2023-01-19 | $2.11 | $2.21 | $2.11 | $2.13 | 50 701 |
| 2023-01-18 | $2.22 | $2.32 | $2.11 | $2.13 | 37 500 |
| 2023-01-17 | $2.24 | $2.32 | $2.15 | $2.24 | 79 814 |
| 2023-01-13 | $2.12 | $2.35 | $2.12 | $2.27 | 80 200 |
| 2023-01-12 | $2.03 | $2.21 | $1.97 | $2.17 | 84 445 |
| 2023-01-11 | $1.97 | $2.04 | $1.94 | $2.04 | 135 200 |
| 2023-01-10 | $1.95 | $1.99 | $1.92 | $1.98 | 72 728 |
| 2023-01-09 | $2.02 | $2.02 | $1.83 | $1.93 | 133 120 |
| 2023-01-06 | $1.80 | $1.98 | $1.76 | $1.98 | 166 400 |
| 2023-01-05 | $1.75 | $1.82 | $1.75 | $1.80 | 48 057 |
| 2023-01-04 | $1.85 | $1.91 | $1.76 | $1.79 | 166 504 |
| 2023-01-03 | $1.55 | $1.82 | $1.53 | $1.82 | 131 292 |
| 2022-12-30 | $1.47 | $1.67 | $1.41 | $1.55 | 450 513 |
| 2022-12-29 | $1.26 | $1.48 | $1.26 | $1.40 | 410 027 |
| 2022-12-28 | $1.46 | $1.53 | $1.16 | $1.19 | 384 573 |
| 2022-12-27 | $1.41 | $1.58 | $1.35 | $1.46 | 162 483 |
| 2022-12-23 | $1.39 | $1.41 | $1.34 | $1.40 | 94 299 |
| 2022-12-22 | $1.18 | $1.39 | $1.17 | $1.37 | 213 528 |
| 2022-12-21 | $1.12 | $1.20 | $1.10 | $1.15 | 119 054 |
| 2022-12-20 | $1.07 | $1.12 | $1.03 | $1.03 | 187 268 |
| 2022-12-19 | $1.13 | $1.19 | $1.08 | $1.11 | 126 151 |
| 2022-12-16 | $1.19 | $1.19 | $1.14 | $1.19 | 97 160 |
| 2022-12-15 | $1.13 | $1.19 | $1.13 | $1.16 | 107 258 |
| 2022-12-14 | $1.22 | $1.23 | $1.15 | $1.17 | 119 321 |
| 2022-12-13 | $1.22 | $1.24 | $1.18 | $1.19 | 229 113 |
| 2022-12-12 | $1.29 | $1.29 | $1.18 | $1.20 | 174 131 |
| 2022-12-09 | $1.30 | $1.40 | $1.25 | $1.27 | 62 653 |
| 2022-12-08 | $1.27 | $1.29 | $1.25 | $1.25 | 121 215 |
| 2022-12-07 | $1.26 | $1.29 | $1.25 | $1.29 | 44 143 |
| 2022-12-06 | $1.31 | $1.33 | $1.25 | $1.28 | 100 892 |
| 2022-12-05 | $1.42 | $1.42 | $1.30 | $1.30 | 140 363 |
| 2022-12-02 | $1.39 | $1.42 | $1.37 | $1.42 | 23 733 |
| 2022-12-01 | $1.36 | $1.45 | $1.36 | $1.41 | 33 570 |
| 2022-11-30 | $1.37 | $1.40 | $1.35 | $1.40 | 44 424 |
| 2022-11-29 | $1.36 | $1.38 | $1.32 | $1.37 | 84 722 |
| 2022-11-28 | $1.50 | $1.50 | $1.36 | $1.37 | 79 143 |
| 2022-11-25 | $1.48 | $1.52 | $1.45 | $1.51 | 40 920 |
| 2022-11-23 | $1.37 | $1.48 | $1.35 | $1.47 | 49 077 |
| 2022-11-22 | $1.43 | $1.43 | $1.29 | $1.37 | 120 644 |
About Cytosorbents Corporation
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complication... CTSO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
